04:47 PM EST, 12/02/2024 (MT Newswires) -- Michael E Prevoznik, Senior Vice President & General Counsel, on November 29, 2024, sold 35,146 shares in Quest Diagnostics ( DGX ) for $5,731,302. Following the Form 4 filing with the SEC, Prevoznik has control over a total of 44,096 shares of the company, with 38,478 shares held directly and 5,618 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1022079/000102207924000208/xslF345X05/wk-form4_1733175791.xml